These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 6254544)

  • 1. [Effects of polymyxin B and E (colistin) on blood coagulation, thrombocyte function, and fibrin structure (author's transl)].
    Klingemann HG; Egbring R; Kaffarnik H
    Arzneimittelforschung; 1980; 30(10):1719-21. PubMed ID: 6254544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the Individual Major Components of Polymyxin B and Colistin in Rats.
    Sivanesan S; Roberts K; Wang J; Chea SE; Thompson PE; Li J; Nation RL; Velkov T
    J Nat Prod; 2017 Jan; 80(1):225-229. PubMed ID: 28080060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymyxin B, colistin, and sodium colistimethate.
    Horton J; Pankey GA
    Med Clin North Am; 1982 Jan; 66(1):135-42. PubMed ID: 6278236
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of polymyxin antibiotics on iodohippurate accumulation in rabbit renal cortical slices.
    Milman N; Dahlager J
    J Antibiot (Tokyo); 1978 Sep; 31(9):906-10. PubMed ID: 213415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergism between chlorhexidine and polymyxins against Pseudomonas aeruginosa.
    Al-Najjar AR; Quesnel LB
    J Appl Bacteriol; 1979 Dec; 47(3):469-76. PubMed ID: 232100
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of disc diffusion, Etest and broth microdilution for testing susceptibility of carbapenem-resistant P. aeruginosa to polymyxins.
    van der Heijden IM; Levin AS; De Pedri EH; Fung L; Rossi F; Duboc G; Barone AA; Costa SF
    Ann Clin Microbiol Antimicrob; 2007 Aug; 6():8. PubMed ID: 17697363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Toxicity of Polymyxins in Human Lung Epithelial Cells.
    Ahmed MU; Velkov T; Lin YW; Yun B; Nowell CJ; Zhou F; Zhou QT; Chan K; Azad MAK; Li J
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics/pharmacodynamics of colistin and polymyxin B: are we there yet?
    Tran TB; Velkov T; Nation RL; Forrest A; Tsuji BT; Bergen PJ; Li J
    Int J Antimicrob Agents; 2016 Dec; 48(6):592-597. PubMed ID: 27793510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility testing of the polymyxins: where are we now?
    Humphries RM
    Pharmacotherapy; 2015 Jan; 35(1):22-7. PubMed ID: 25329490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reliability of the colistin disk test in identification of Serratia marcescens and Serratia liquefaciens.
    von Graevenitz A; Zollinger-Iten J
    Eur J Clin Microbiol; 1987 Feb; 6(1):70-1. PubMed ID: 3032610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide.
    Sader HS; Rhomberg PR; Farrell DJ; Jones RN
    Diagn Microbiol Infect Dis; 2015 Dec; 83(4):379-81. PubMed ID: 26415906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between the polymyxins and gentamicin in preventing endotoxin-induced intravascular coagulation and leukopenia.
    Corrigan JJ; Bell BM
    Infect Immun; 1971 Nov; 4(5):563-6. PubMed ID: 4343409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention by glucocorticoids of disseminated intravascular coagulation induced by endotoxin: mechanisms.
    Latour JG; Leger C
    J Lab Clin Med; 1975 Jun; 85(6):934-49. PubMed ID: 1094078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The susceptibility of enteropathogenic and non-enteropathogenic porcine Escherichia coli strains to polymyxins and other antibiotics.
    Larsen JL; Søgaard H
    Nord Vet Med; 1981; 33(9-11):393-402. PubMed ID: 6276857
    [No Abstract]   [Full Text] [Related]  

  • 15. Polymyxin B: similarities to and differences from colistin (polymyxin E).
    Kwa A; Kasiakou SK; Tam VH; Falagas ME
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):811-21. PubMed ID: 17914915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of polymyxin B on endotoxemia in severe liver diseases (author's transl)].
    Iwasaki M; Kumashiro R; Wada T; Maeyama T; Nagata E; Kawaguchi M; Abe H; Tanikawa K
    Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):241-8. PubMed ID: 6285045
    [No Abstract]   [Full Text] [Related]  

  • 17. Cationic antibiotics and phospholipase C as tools in the study of phospholipid structure and function. I. Inhibition of the in vitro clotting system by cationic antibiotics.
    Ottolenghi AC
    Can J Biochem; 1967 Feb; 45(2):239-44. PubMed ID: 4290011
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Pharmacokinetics, Pharmacodynamics and Toxicodynamics of Polymyxins: Implications for Therapeutic Use.
    Nation RL; Forrest A
    Adv Exp Med Biol; 2019; 1145():219-249. PubMed ID: 31364081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute renal failure in disseminated intravascular coagulation. Experimental studies of the induction and prevention of renal fibrin deposition.
    Whitaker AN
    Prog Biochem Pharmacol; 1974; 9():45-64. PubMed ID: 4373764
    [No Abstract]   [Full Text] [Related]  

  • 20. Endotoxin-induced intravascular coagulation: prevention with polymyxin B sulfate.
    Corrigan JJ; Bell BM
    J Lab Clin Med; 1971 May; 77(5):802-10. PubMed ID: 4326749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.